Glaxo sales tripped by Avandia worries
Wednesday, July 25th, 2007Britain’s biggest drugmaker said revenues in the second quarter of the year fell from 5.81bn to 5.67bn, with sales of Avandia down 22% to 349m.
Last year Avandia was one of Glaxo’s top-selling drugs, bringing in 1.4bn - second only to the 3.3bn reaped from sales of asthma treatment Advair.
Despite the current problems with […]